Exponent INC (EXPO) — SEC Filings

Overview

Exponent INC (EXPO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 7, 2025: Exponent Inc. (EXPO) reported mixed financial results for the nine months ended October 3, 2025. Revenues increased to $434.589 million, up 3.04% from $421.748 million in the prior year period. However, net income decreased by 4.88% to $81.247 million, compared to $85.413 million for the nine months

Sentiment Summary

Across 32 filings, the sentiment breakdown is: 1 bullish, 30 neutral, 1 mixed. The dominant filing sentiment for Exponent INC is neutral.

Filing Type Overview

Exponent INC (EXPO) has filed 6 10-Q, 13 8-K, 2 DEF 14A, 2 10-K/A, 2 10-K, 7 SC 13G/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (32)

• Exponent's Q3 Revenue Up, But Net Income and Cash Decline — 10-Q · Nov 7, 2025 Risk: medium
  Exponent Inc. (EXPO) reported mixed financial results for the nine months ended October 3, 2025. Revenues increased to $434.589 million, up 3.04% from $421.748
• Exponent Inc. Files 8-K on Financials and Operations — 8-K · Oct 30, 2025 Risk: low
  Exponent, Inc. filed an 8-K on October 30, 2025, reporting on its Results of Operations and Financial Condition. The filing also includes Regulation FD Disclosu
• Exponent Posts Strong Q2 Growth, Net Income Up 11.7% — 10-Q · Aug 8, 2025 Risk: low
  Exponent Inc. reported a robust second quarter for 2025, with total revenues increasing to $140.2 million for the three months ended July 4, 2025, up from $130.
• Exponent Inc. Files 8-K on Financials — 8-K · Jul 31, 2025 Risk: low
  Exponent, Inc. filed an 8-K on July 31, 2025, reporting on its Results of Operations and Financial Condition, as well as Regulation FD Disclosure and Financial
• Exponent Inc. Reports on Shareholder Vote — 8-K · Jun 10, 2025 Risk: low
  Exponent, Inc. filed an 8-K on June 10, 2025, reporting on a matter submitted to a vote of its security holders on June 5, 2025. The filing details the company'
• Exponent Inc. Files Q1 2025 10-Q — 10-Q · May 9, 2025 Risk: low
  Exponent Inc. filed its 10-Q for the period ending April 4, 2025. The filing details financial performance and operational updates. Key financial data points in
• Exponent, Inc. Files 8-K on Financials and Disclosures — 8-K · May 1, 2025 Risk: low
  Exponent, Inc. filed an 8-K on May 1, 2025, reporting on its Results of Operations and Financial Condition, and providing Regulation FD Disclosures. The filing
• Exponent Inc. DEF 14A: Executive Compensation & Stock Awards — DEF 14A · Apr 21, 2025 Risk: low
  Exponent Inc. filed its DEF 14A on April 21, 2025, detailing executive compensation and stock awards. The filing covers the fiscal year ending January 3, 2025,
• Exponent Inc. Files 10-K/A Amendment — 10-K/A · Apr 18, 2025 Risk: low
  Exponent, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended January 3, 2025. The company, incorporated in Delaware with its princi
• Exponent Inc. Files 2025 10-K — 10-K · Feb 28, 2025 Risk: low
  Exponent Inc. filed its 10-K for the fiscal year ending January 3, 2025, reporting on its management consulting services. The company's fiscal year end is Janua
• Exponent Inc. Files 8-K on Financials — 8-K · Feb 6, 2025 Risk: low
  Exponent, Inc. filed an 8-K on February 6, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosu
• Exponent Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 1, 2024 Risk: low
  Exponent Inc. filed its 10-Q for the period ending September 27, 2024. The company, headquartered in Menlo Park, CA, reported on its financial performance and b
• Exponent Inc. Files 8-K for Financial Updates — 8-K · Oct 24, 2024 Risk: low
  Exponent, Inc. filed an 8-K on October 24, 2024, to report on its results of operations and financial condition, as well as to provide Regulation FD disclosures
• SC 13G/A Filing — SC 13G/A · Oct 3, 2024
• Exponent Inc. Q2 2024 Sales Hit $59.5M — 10-Q · Aug 2, 2024 Risk: low
  Exponent Inc. filed its 10-Q for the period ending June 28, 2024. The company reported net sales of $59.5 million for the second quarter of 2024. Key financial
• Exponent Inc. Files 8-K on Financials — 8-K · Jul 25, 2024 Risk: low
  Exponent Inc. filed an 8-K on July 25, 2024, reporting on its financial condition and results of operations. The filing also includes disclosures under Regulati
• Exponent Inc. Enters New Credit Agreement — 8-K · Jun 24, 2024 Risk: low
  On June 19, 2024, Exponent Inc. entered into a material definitive agreement, specifically a credit agreement, which creates a direct financial obligation for t
• Exponent Inc. Reports on Shareholder Vote Matters — 8-K · Jun 11, 2024 Risk: low
  Exponent Inc. filed an 8-K on June 11, 2024, reporting on matters submitted to a vote of security holders on June 6, 2024. The filing details the company's prin
• Exponent Inc. Files 10-Q for Period Ending March 29, 2024 — 10-Q · May 3, 2024 Risk: low
  EXPONENT INC (EXPO) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Revenue for the period ending March 29, 2024, was $59.5 million. The company re
• Exponent Inc. Files 8-K on Financials — 8-K · Apr 25, 2024 Risk: low
  Exponent, Inc. filed an 8-K on April 25, 2024, reporting on its financial condition and results of operations. The filing also includes Regulation FD disclosure
• Exponent Inc. Files DEF 14A Proxy Statement — DEF 14A · Apr 22, 2024 Risk: low
  EXPONENT INC (EXPO) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. Filing is a DEF 14A proxy statement for Exponent Inc. The filing pertains
• Exponent, Inc. Files Amendment No. 1 to Annual Report on Form 10-K — 10-K/A · Apr 17, 2024 Risk: low
  EXPONENT INC (EXPO) filed a Amended Annual Report (10-K/A) with the SEC on April 17, 2024. Exponent, Inc. filed an amendment (10-K/A) to its annual report for t
• SC 13G/A Filing — SC 13G/A · Apr 10, 2024
• Exponent Inc. Appoints New Director, Sees Departure — 8-K · Mar 1, 2024 Risk: low
  Exponent Inc. announced on February 26, 2024, the departure of director Dr. Steven D. Wood. Concurrently, the company elected Dr. Michael L. T. Webb as a new Cl
• Exponent Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 23, 2024 Risk:
  EXPONENT INC (EXPO) filed a Annual Report (10-K) with the SEC on February 23, 2024. Exponent Inc. filed its 10-K report for the fiscal year ending December 29,
• Kayne Anderson Rudnick Amends Exponent Inc. (EXPO) Stake — SC 13G/A · Feb 13, 2024 Risk: low
  Kayne Anderson Rudnick Investment Management LLC, a California-based investment firm, filed an amended SC 13G/A on February 13, 2024, indicating their ownership
• Vanguard Trims Exponent Inc. Stake to 13.7% as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024 Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, updating its ownership in Exponent Inc. As of December 29, 2023, Va
• Neuberger Berman Amends EXPO Stake, Files 15th 13G/A — SC 13G/A · Feb 12, 2024 Risk: low
  Neuberger Berman Group LLC, a Delaware-based investment firm, filed an amended SC 13G/A on February 12, 2024, indicating their beneficial ownership of EXPONENT
• Exponent Files Routine 8-K; No Material News Disclosed — 8-K · Feb 8, 2024 Risk: low
  Exponent, Inc. filed an 8-K on February 8, 2024, reporting an event that occurred on February 2, 2024. This filing is a standard current report, indicating no m
• Exponent Files 8-K on Financial Results & Reg FD Disclosure — 8-K · Feb 1, 2024
  Exponent, Inc. filed an 8-K on February 1, 2024, to report on its 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure.' This filing in
• BlackRock Amends Exponent Inc. Stake (SC 13G/A) — SC 13G/A · Jan 23, 2024
  BlackRock Inc. filed an amended Schedule 13G/A on January 23, 2024, indicating a change in its ownership of Exponent Inc. common stock as of December 31, 2023.
• Conestoga Capital Advisors Updates EXPO Stake as of Dec 31, 2023 — SC 13G/A · Jan 5, 2024
  Conestoga Capital Advisors, LLC, an investment adviser based in Wayne, PA, filed an amended Schedule 13G/A on January 5, 2024, indicating their beneficial owner

Risk Profile

Risk Assessment: Of EXPO's 26 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 25 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Exponent INC's most recent 10-Q filing (Nov 7, 2025):

• Revenue: $434.589M
• Net Income: $81.247M
• EPS: $1.59
• Debt-to-Equity: N/A
• Cash Position: $207.380M
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• Catherine Ford Corrigan
• Dr. Steven D. Wood
• Dr. Michael L. T. Webb

Industry Context

Exponent Inc. operates in the scientific and engineering consulting services industry. This sector is characterized by a demand for specialized expertise across various disciplines, including engineering, materials science, and environmental consulting. Key trends include the increasing complexity of product development, stringent regulatory environments, and the need for independent expert analysis in litigation and insurance claims. Competition comes from a range of firms, from large, diversified engineering consultancies to smaller, niche specialists.

Top Tags

amendment (6) · institutional-ownership (5) · financial-reporting (4) · 10-Q (4) · financials (3) · regulation-fd (3) · 8-K (3) · Exponent Inc. (3) · Consulting Services (2) · Revenue Growth (2)

Key Numbers

• Revenues: $434.589M — Increased by 3.04% for the nine months ended October 3, 2025, from $421.748M in the prior year.
• Net Income: $81.247M — Decreased by 4.88% for the nine months ended October 3, 2025, from $85.413M in the prior year.
• Cash and Cash Equivalents: $207.380M — Decreased by 19.9% from $258.901M at January 3, 2025, to October 3, 2025.
• Common Stock Repurchases: $72.712M — Significant cash outflow for the nine months ended October 3, 2025.
• Dividends Paid: $46.652M — Significant cash outflow for the nine months ended October 3, 2025.
• Basic Net Income Per Share: $1.59 — Decreased from $1.67 in the prior year period.
• Time and Materials Revenues: 79% — Represents the majority of revenue for the nine months ended October 3, 2025.
• Increase in Accounts Receivable: $22.686M — Negative impact on cash flow from operating activities for the nine months ended October 3, 2025.
• Total Revenues for Q2 2025: $140.2M — Increased by 7.4% from $130.5 million in Q2 2024
• Net Income for Q2 2025: $25.8M — Increased by 11.7% from $23.1 million in Q2 2024
• Diluted EPS for Q2 2025: $0.50 — Increased from $0.45 in Q2 2024
• Total Revenues for Six Months Ended July 4, 2025: $275.5M — Increased from $256.1 million in the comparable 2024 period
• Engineering and Other Scientific Segment Revenue for Q2 2025: $118.9M — Primary revenue contributor for the quarter
• Environmental and Health Segment Revenue for Q2 2025: $21.3M — Secondary revenue contributor for the quarter
• Cash and Cash Equivalents as of July 4, 2025: $105.3M — Indicates strong liquidity and financial health

Forward-Looking Statements

• {"claim":"Vanguard will continue to adjust its stake in Exponent Inc. based on market conditions and its internal investment strategies.","entity":"The Vanguard Group","targetDate":"Next SC 13G/A filing","confidence":"high"}

Frequently Asked Questions